⚠️ Medical Disclaimer: This page contains important safety information. Always consult a healthcare professional before taking Brahmi or any supplement.
Brahmi powder and supplement capsules for safety

Safety & Side Effects

Understanding risks, contraindications, and safe use of Bacopa monnieri

⚠️ Important: The U.S. Food and Drug Administration (FDA) has not evaluated Brahmi (Bacopa monnieri) for the treatment or prevention of any disease. The information below is a summary of reported safety data from clinical trials and traditional use. It does not replace professional medical advice.

Overall Safety Profile

Brahmi plant in a pot for safe home cultivation

In clinical trials, Bacopa monnieri is generally well-tolerated at studied doses (300–600 mg/day of standardized extract) for up to 12 months. The majority of reported side effects are mild to moderate in severity and resolve upon discontinuation.

A 2018 systematic review of Bacopa clinical trials concluded that the herb has a favorable safety profile, with adverse event rates similar to placebo in most studies. However, long-term safety data beyond 12 months is limited.

Common Side Effects

Woman in saree studying safety information about Brahmi

The most frequently reported side effects are gastrointestinal in nature:

  • Nausea — reported in 5–10% of trial participants
  • Dry mouth — common, usually mild
  • Abdominal cramping or bloating
  • Increased bowel movements or loose stools
  • Diarrhea — more common at higher doses
  • Fatigue or sedation in some individuals

Less common side effects include headache, dizziness, and increased heart rate. These are typically dose-dependent and less likely when starting with a lower dose and gradually increasing.

Who Should Avoid Brahmi

  • Pregnant or breastfeeding women — insufficient safety data (see below)
  • People with hyperthyroidism — may increase thyroid hormone levels
  • People with bradycardia (slow heart rate) — may further slow heart rate
  • People with peptic ulcers — may increase stomach acid
  • People with intestinal obstruction
  • Children under 12 — limited safety data (Ayurvedic use only under supervision)

Drug Interactions

While clinically significant interactions are rarely reported, the following theoretical interactions should be considered:

Drug / ClassPotential Interaction
Anticholinergic drugsBrahmi may enhance acetylcholine levels — theoretical additive effect
Thyroid medicationsMay increase T4 levels — monitor thyroid function
Sedatives / AnxiolyticsPossible additive sedative effect
Anticoagulants (e.g., warfarin)Theoretical interaction — monitor INR if combining
Cholinergic drugsPossible additive cholinergic effects
MAOIsTheoretical interaction — limited data

If you take any prescription medication, consult your doctor or pharmacist before starting Brahmi.

Pregnancy & Breastfeeding

⚠️ Bacopa monnieri is not recommended during pregnancy or breastfeeding.

There is insufficient human data on safety during pregnancy. Animal studies have yielded mixed results, with some older studies suggesting possible uterotonic (uterine-stimulating) effects at very high doses. Until more is known, it is safest to avoid Brahmi entirely if you are pregnant, planning to become pregnant, or breastfeeding.

Thyroid Considerations

Several animal studies have demonstrated that Bacopa monnieri increases T4 (thyroxine) levels, likely through stimulation of thyroid hormone synthesis. In one rat study, a 300 mg/kg dose of Bacopa extract increased T4 levels by approximately 41% after 15 days.

The clinical significance for humans is not well established, but caution is warranted:

  • Individuals with hyperthyroidism should avoid Brahmi
  • Those taking thyroid replacement medication should monitor thyroid function if using Brahmi
  • Anyone with a known thyroid condition should consult their doctor before use

Overdose & Toxicity

There are no documented cases of serious toxicity from Brahmi in humans. Studies using doses up to 1,200 mg/day of standardized extract for short periods have not reported severe adverse events. However, higher doses significantly increase the likelihood and severity of gastrointestinal side effects.

The LD50 (lethal dose for 50% of subjects) in rats is very high (approximately 2,000 mg/kg body weight), indicating a wide safety margin in preclinical models.

Safe Use Tips

  • Start low, go slow: Begin with half the recommended dose for the first week.
  • Take with food: Reduces gastrointestinal irritation and improves absorption.
  • Stay hydrated: Drink plenty of water throughout the day.
  • Monitor yourself: Note any changes in digestion, mood, sleep, or heart rate.
  • Discontinue if: You experience persistent nausea, diarrhea, unusual fatigue, or palpitations.
  • Inform your doctor: Always tell your healthcare provider about all supplements you are taking.

⚠️ Final Medical Disclaimer: The information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before taking Brahmi or any dietary supplement. The FDA has not evaluated Brahmi for safety or efficacy in treating any condition. Never delay seeking professional medical advice because of something you read on this site.